Prognostic scoring models are relevant in conditions where associated morbidity and
mortality are high. It is therefore not surprising that several of these exist for acute alcoholic
hepatitis (AAH). The main value of these scores is to provide validated risk assessment at
baseline, which allows for prognostication and follow-up information on response to a
specific therapy or to assess for spontaneous improvement in cases when treatment is
declined or not indicated. Although multiple randomized controlled clinical trials have used …